Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-410P is a human pseudogene derived from the U6 small nuclear RNA gene family. Functional U6 small nuclear RNA (snRNA) is a critical non-coding RNA component of the spliceosome, a complex essential for pre-mRNA splicing in eukaryotic nuclei[1][2]. However, RNU6-410P is a duplicated (pseudogenic) copy and does not produce a functional RNA product[3][4]. U6 snRNA pseudogenes are common in vertebrate genomes, often generated through retrotransposition or genomic duplication; they are generally not transcribed or functional, though they retain high sequence similarity to active U6 genes[3][4]. There is no evidence that RNU6-410P plays a biological or pathological role in human health or disease.
Not applicable. No therapeutic agents act on this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 410, pseudogene (RNU6-410P).